Hervé Ghesquieres, Malgorzata Krawczyk-Kulis, Dominik Chraniuk, Michal Kwiatek, Hendrik Nogai, Chadi Saba, Adam Falkowski, Katarzyna Kucharz, Michal Kulesza, Ruth Curley, Gary Wilkinson, Przemyslaw Juszczynski, Francesco Bertoni, Daniela Bellarosa, Antonio Galleu, Ira Gupta, Monika Dlugosz-Danecka, Wojciech Jurczak, Guillaume Cartron, Grzegorz Nowakowski. "An open-label, Phase 2 study of dapolsertib (MEN1703, SEL24) as monotherapy and in combination with glofitamab in patients with relapsed or refractory aggressive B-cell non-Hodgkin lymphoma." Blood, 2025. doi:10.1182/blood-2025-5481